Evidence map›Paper›PMID 23236316›Full record

ArticleTuberculosis and respiratory diseases2012

Bronchiectasis.

Changhwan Kim, Dong-Gyu Kim

Abstract read
In one paragraph

Article in Tuberculosis and respiratory diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Nurse-led versus doctor-led care for bronchiectasis.The Cochrane database of systematic reviews · 2018
    Review
  5. Article
  6. The effects of bronchiectasis on asthma exacerbation.Tuberculosis and respiratory diseases · 2014
    Article
  7. Common variable immunodeficiency disorder - An uncommon cause for bronchiectasis.Lung India : official organ of Indian Chest Society · 2014
    Article
  8. Article
  9. Article
  10. Lung or liver: An imaging dilemma on Tc-99m macroaggregated albumin lung perfusion scintigraphy.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Changhwan KimDepartment of Internal Medicine and Lung Research Institute, Hallym University College of Medicine, Chuncheon, Korea.
Dong-Gyu Kim

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The frequency of diagnosing bronchiectasis is increasing around the world. Cystic fibrosis is the most common inherited cause of bronchiectasis, but there is increasing recognition of significant numbers of patients with bronchiectasis from various causes. With increasing awareness of bronchiectasis, a significant number of research, concerning the causes and treatments, were published over the past few years. Investigation of the underlying cause of bronchiectasis is the most important key to effective management. The purpose of this report is to review the immunological abnormalities that cause bronchiectasis in those that the cystic fibrosis has been excluded, identify the available evidences of current management, and discuss several controversies in the treatment of this disorder.

Indexed as

BronchiectasisEtiologyImmunologic Deficiency SyndromesTherapeutics

Identifiers

PMID23236316
PMCPMC3517943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.